Botulinum Toxin Extracranial Diffusion for Cerebral Vasodilation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical treatments for conditions associated with impaired cerebral blood flow, such as stroke and vascular diseases, are inadequate due to the difficulty in accessing and treating the cerebral arteriolar circulation, and existing methods carry risks like intra-cerebral hemorrhage and limited effectiveness.
Innovation Solution
The use of botulinum toxin injections in extracranial regions, allowing the toxin to diffuse through the skull and penetrate deep into the brain, causing vasodilation and reducing flow resistance, thereby increasing cerebral blood flow and treating conditions like cerebrovascular insufficiency, retinal vascular disease, congestive heart failure, and renal arterial insufficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for impaired cerebral blood flow, then treatment safety is maintained, but treatment effectiveness is insufficient due to inability to access cerebral arteriolar circulation
Solution Approach 1:
The patent uses botulinum toxin as an intermediary substance that can be injected extracranially and will diffuse through the skull to reach the cerebral arteriolar circulation. This mediator bypasses the difficulty of direct access to deep brain vessels while still achieving the therapeutic effect of vasodilation and improved blood flow.
Solution Approach 2:
The patent replaces mechanical/physical access methods (such as surgical intervention or catheterization) with a chemical/biological approach using botulinum toxin diffusion. Instead of physically navigating to the cerebral arterioles, the toxin is delivered systemically and reaches the target through passive diffusion, substituting mechanical access with a biochemical mechanism.
2Reliability
If invasive methods are used to access cerebral vessels, then treatment effectiveness improves, but risk of intra-cerebral hemorrhage increases
Solution Approach 1:
Botulinum toxin serves as a non-invasive intermediary that achieves therapeutic effects without direct mechanical contact with cerebral vessels. The toxin diffuses through tissue barriers to reach its target, eliminating the need for invasive procedures that could cause hemorrhage while maintaining treatment effectiveness.
Solution Approach 2:
The patent converts the traditionally harmful nature of botulinum toxin (a potent neurotoxin) into a beneficial therapeutic agent by utilizing its ability to block acetylcholine release, which results in vasodilation of cerebral arterioles. What is typically a harmful substance is repurposed to treat cerebrovascular disease through its side effect of causing vasodilation.
3Ease of operation
If botulinum toxin is injected extracranially to reach deep brain structures, then accessibility to cerebral circulation improves, but risk of brain toxicity may increase
Solution Approach 1:
The patent utilizes the local diffusion properties of botulinum toxin, where the toxin concentrates at specific sites along its diffusion path, particularly at the cerebral arteriolar circulation. This localized concentration achieves therapeutic effects at the target while minimizing systemic distribution and potential brain toxicity.
Solution Approach 2:
The patent employs specific dosing parameters and formulation characteristics of botulinum toxin to control its diffusion and concentration. By carefully selecting the dose and formulation, the toxin achieves sufficient concentration at the cerebral arterioles for therapeutic effect while remaining below toxic thresholds in the brain parenchyma.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively increases blood flow to affected areas, preventing progression or enhancing recovery from various diseases, including cerebrovascular diseases, retinal vascular diseases, congestive heart failure, and renal arterial insufficiency, with a high safety profile and minimal risk of brain toxicity.
Implementation Method 1
allowing the botulinum toxin to spread within the deep brain structure
Data Source
AI summary
Methods of using botulinum toxin based pharmaceuticals are disclosed. The methods cause vasodilatation and decreased flow resistance of certain vascular beds for the purpose of increasing blood flow to a region in order to positively impact deterioration from a number of diseases.